Primary cardiac sarcomas: A multi‐national retrospective review
Tom Wei‐Wu Chen(National Taiwan University), Jeremy Lewin(Mount Sinai Hospital), Amirrtha Srikanthan(BC Cancer Agency), Herbert H. Loong(Memorial Sloan Kettering Cancer Center), Jagdish Butany(University of Toronto), Alona Zer(Rambam Health Care Campus), Robert J. Cusimano(University Health Network), Yun‐Chieh Liang(National Taiwan University), Chin‐Hao Chang(The University of Sydney), Reeta Barua(University of Toronto), Albiruni R. Abdul Razak(Mount Sinai Hospital), Zaza Iakobishvili(Ben-Gurion University of the Negev)
Cited by 60
Related Papers
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
|The Lancet Oncology|2019|1.7k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767